General MedicationsORALStandard
ISENTRESS
RALTEGRAVIR POTASSIUM
Standard Dose
EQ 100MG BASE/PACKET
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ISENTRESS is listed in Drugs@FDA under application 205786 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient RALTEGRAVIR POTASSIUM Form and strength POWDER;ORAL - EQ 100MG BASE/PACKET Sponsor MSD SUB MERCK Submission history Latest submission status date: 2021-05-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview ISENTRESS is listed in Drugs@FDA under application 205786 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient RALTEGRAVIR POTASSIUM Form and strength POWDER;ORAL - EQ 100MG BASE/PACKET Sponsor MSD SUB MERCK Submission history Latest submission status date: 2021-05-18 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.